The specification of what is to be considered “adequate remuneration” will also provide guidance on what would be considered a “reasonable royalty” to be agreed upon in negotiations on a voluntary licence between the patent holder and the generic producer.
The specification of what is to be considered “adequate remuneration” will also provide guidance on what would be considered a “reasonable royalty” to be agreed upon in negotiations on a voluntary licence between the patent holder and the generic producer.